Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility Study

ClinicalTrials.gov ID: NCT00596726

Public ClinicalTrials.gov record NCT00596726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

RECOVER I: IMPELLA® RECOVER® LP/LD 5.0 Support System: A Clinical Safety & Feasibility Study

Study identification

NCT ID
NCT00596726
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Abiomed Inc.
Industry
Enrollment
17 participants

Conditions and interventions

Interventions

  • IMPELLA LP/LD 5.0 Device

Device

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2006
Primary completion
Mar 31, 2010
Completion
Apr 30, 2010
Last update posted
May 26, 2010

2006 – 2010

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
University of Maryland Baltimore Maryland 21201
Massach General Hospital Boston Massachusetts 02114
Brigham & Womens Boston Massachusetts 02115
Robert Wood Johnson New Brunswick New Jersey 08903
Columbia Presbyterian Hospital New York New York 10032
Hershey Medical Center Hershey Pennsylvania 17033
Texas Heart Houston Texas 777030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00596726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 26, 2010 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00596726 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →